526546 — Choksi Laboratories Share Price
- IN₹879.02m
- IN₹1.18bn
- IN₹366.95m
- 64
- 23
- 91
- 65
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 3.82 | ||
Price to Tang. Book | 3.88 | ||
Price to Free Cashflow | 19.85 | ||
Price to Sales | 2.12 | ||
EV to EBITDA | 10.48 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 11.18% | ||
Return on Equity | 5.76% | ||
Operating Margin | 11.88% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 281.59 | 256.88 | 300.42 | 344.4 | 366.95 | n/a | n/a | 1.69% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | +516.81 | -11.99 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Choksi Laboratories Limited is an India-based provider of contract testing and analytical services. The Company analyzes, for its clients, or as a regulatory requirement, pharmaceuticals, food and agricultural products, construction materials, chemicals, calibration and environmental monitoring services. It operates through a single segment, which is analysis and testing. The Company's services include contract laboratory services, instrument calibration and validation services, environmental management services, clinical research, consultancy, and assaying and hallmarking (gold and silver). The Company's contract laboratory services include pharmaceutical analysis, food and beverages analysis, water analysis and construction material analysis. Its calibration services include laboratory and on-site calibration for test equipment, process equipment and, in many cases, end-user equipment; plant shutdown calibration, and consultancy for setting up an in-house calibration laboratory.
Directors
- Vyangesh Choksi CFO
- Sanjay Chourey CCO
- Sunil Choksi MDR
- Himika Choksi EDR (41)
- Stela Choksi EDR
- Mayank Pandey IND
- Ratnesh Sadoriya IND
- N. Mani NID
- Sudarshan Shastri NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 29th, 1993
- Public Since
- June 13th, 1994
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
Bombay Stock Exchange
- Shares in Issue
- 6,965,300

- Address
- 6/3 Manoramaganj,, INDORE, 452010
- Web
- http://www.choksilab.com/
- Phone
- +91 7313501112
- Contact
- Prakhar Dubey
- Auditors
- M/s.Prateek Jain & Co
Upcoming Events for 526546
Q1 2026 Choksi Laboratories Ltd Earnings Release
Choksi Laboratories Ltd Annual Shareholders Meeting
Similar to 526546
ABHISHEK FINLEASE
Bombay Stock Exchange
Adtech Systems
Bombay Stock Exchange
Alka Securities
Bombay Stock Exchange
Alkosign
Bombay Stock Exchange
All Metal Process Industries Pvt
Bombay Stock Exchange
FAQ
As of Today at 19:55 UTC, shares in Choksi Laboratories are trading at IN₹126.20. This share price information is delayed by 15 minutes.
Shares in Choksi Laboratories last closed at IN₹126.20 and the price had moved by +93.53% over the past 365 days. In terms of relative price strength the Choksi Laboratories share price has outperformed the S&P BSE 100 Index by +82.31% over the past year.
There is no consensus recommendation for this security.
Find out moreChoksi Laboratories does not currently pay a dividend.
Choksi Laboratories does not currently pay a dividend.
Choksi Laboratories does not currently pay a dividend.
To buy shares in Choksi Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹126.20, shares in Choksi Laboratories had a market capitalisation of IN₹879.02m.
Here are the trading details for Choksi Laboratories:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 526546
Based on an overall assessment of its quality, value and momentum Choksi Laboratories is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Choksi Laboratories. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +115.43%.
As of the last closing price of IN₹126.20, shares in Choksi Laboratories were trading +41.38% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Choksi Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹126.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Choksi Laboratories' management team is headed by:
- Vyangesh Choksi - CFO
- Sanjay Chourey - CCO
- Sunil Choksi - MDR
- Himika Choksi - EDR
- Stela Choksi - EDR
- Mayank Pandey - IND
- Ratnesh Sadoriya - IND
- N. Mani - NID
- Sudarshan Shastri - NID